Cumberland Pharmaceuticals, Inc.
2525 West End Avenue
Suite 950
Nashville,
TN 37203
United States - Map
Phone: 615-255-0068
Fax: 615-255-0094
Website: http://www.cumberlandpharma.com
| Index Membership: | N/A | | Sector: | Healthcare | | Industry: | Drug Manufacturers - Other | | Full Time Employees: | 106 |
|
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, engages in the acquisition, development, and commercialization of branded prescription products for the hospital acute care and gastroenterology markets primarily in the United States. Its principal products include Acetadote, an intravenous formulation of N-acetylcysteine indicated for the treatment of acetaminophen poisoning; Caldolor, an intravenous formulation of ibuprofen for the treatment of pain and fever; and Kristalose, a prescription laxative administered orally for the treatment of constipation. It also develops Hepatoren injection, which is in Phase II clinical development for the treatment of hepatorenal syndrome. The company markets and sells its products through sales representatives and managers. Cumberland Pharmaceuticals, Inc. was incorporated in 1999 and is headquartered in Nashville, Tennessee. Key Statistics
| |
| | Pay | Exercised | Mr. A. J. Kazimi MBA,
55
Founder, Chairman, Chief Exec. Officer and Pres | 603.00k | 0.00 | Mr. Richard S. Greene ,
48
Chief Financial Officer, Principal Accounting Officer and VP | 275.00k | 0.00 | Mr. Leo Pavliv R.Ph.,
52
Chief Devel. Officer and Sr. VP of Operations | 485.00k | 0.00 | Mr. James L. Herman ,
58
Chief Compliance Officer and VP of National Accounts | 267.00k | 0.00 | Mr. Martin E. Cearnal ,
68
Chief Commercial Officer, Sr. VP and Director | 395.00k | 0.00 |
|
| | Amounts are as of 2012-12-30 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year. | | Currency in USD. |
|
0.01(0.20%) May 17, 4:00PM EDT